Notícias

KLAC's AI-driven process-control demand, advanced-packaging growth, robust backlog and strong capital returns support further upside despite margin pressure.

MKS (MKSI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

The average of price targets set by Wall Street analysts indicates a potential upside of 49.8% in MKS (MKSI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The gain was set before the results crossed, and its optical peers rose with it.

MKS' Q2 earnings and revenues beat estimates as broad end-market growth and stronger margins fuel an upbeat third-quarter outlook.

MKS (MKSI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

MKS (MKSI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

The AI equipment demand that repriced Lam Research stock was named, sized and already visible in the reported numbers before the run began.

MKS (MKSI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Kimball is investing in medical manufacturing, automation and acquisitions to support higher margins and sustainable long-term growth.

MKS Inc. (NASDAQ:MKSI) is one of the 10 Best Stocks to Buy in Glen Kacher’s Light Street Portfolio. On June 25, 2026, MKS Inc. (NASDAQ:MKSI) announced a $25 million expansion of its Atotech equipment manufacturing facility in Guangzhou, China. The expansion aiming to support the global AI build-out, is expected to be completed before the […]

UCTT's growth story remains intact as rising fab investments, strong customer demand and strategic execution fuel momentum.

Lam Research stock and several peers hit record highs as chipmakers invest in new gear amid the AI megatrend.

The chip-equipment maker is posting record results at the heart of the AI buildout, but its premium price and history of sharp downturns frame a difficult decision for investors.

Applied Materials stock surged to a record high after getting two price-target hikes. AMAT stock has been on a tear this year.

MKS (MKSI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

MKS (MKSI) has drawn fresh attention after first quarter 2026 results topped analyst expectations, with revenue of US$1.08b and earnings surprises supported by strong semiconductor, electronics, and packaging demand. See our latest analysis for MKS. The share price reaction has been strong, with a year to date share price return of 78.66% and a very large 1 year total shareholder return of 291.99%, which suggests that investors view earnings surprises and AI related demand as meaningful. If...